In-silico approaches in designing new drug candidates (THICAPA and POET) for alzheimer’s disease

Authors

  • Ahmad Marwazi M. Suhaimi School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
  • Ezatul Ezleen Kamarulzaman School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
  • Habibah A. Wahab School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia & Faculty of Pharmacy, Padjajaran University, Jatinangor, Indonesia
  • Mohd Shareduwan Mohd Kasihmuddin School of Mathematical Sciences, Universiti Sains Malaysia, Penang, Malaysia

DOI:

https://doi.org/10.46542/pe.2024.246.3542

Keywords:

Alzheimer’s disease, Binding free energy, In-silico, Molecular docking, POET, THICAPA

Abstract

Background: Memory and cognitive regression are the first symptoms of Alzheimer’s Disease (AD), which may progress to speech and mobility challenges which affecting around 35% of those who over the age of 80 years old. Preliminary study shows THICAPA and Palm Oil Extracted Tocotrienol (POET) is effective in reducing AD symptoms in Dorosophila melagnoster.

Objective: The purpose of this study is to elucidate the binding interaction between THICAPA and POET towards APP and PS1 at the molecular level.

Method: The binding of THICAPA and POET towards APP (PDB ID: 6SZF), PS1 (PDB ID: 7D8X), and their genetic mutation variations (APP variant n = 6, PS1 variant n = 200) have been studied using in-sillico molecular docking (Autodock 4.2) approaches and comparing the Binding Free Energy (BFE) of the binding interactions.

Result: From the 416 dockings (n = 100 per docking, ∑n = 41,600), we revealed that all dockings had negative BFE which showed the low BFE towards both APP (E22K variant ΔG THICAPA = -6.20 kcal/mol, D23N variant ΔG POET = -7.25 kcal/mol) and PS1 (A413V variant ΔG THICAPA = -8.34 kcal/mol, L174M variant ΔG POET = -10.94 kcal/mol).

Conclusion: THICAPA and POET showed a negative BFE with APP and PS1. Thus, the result suggesting that THICAPA and POET may be the potential drug candidates for treating AD.

References

Alzheimer’s Disease International. (2014). Dementia in the Asia Pacific Region. https://www.alzint.org/u/Dementia-Asia-Pacific-2014.pdf

BIOVIA, D. S. (2019). Discovery Studio Client, 16.1.Dassault Systèmes. https://www.3ds.com/products-services/biovia/resource-center/citations-and-references/

Du, X., Li, Y., Xia, Y. L., Ai, S. M., Liang, J., Sang, P., Ji, X. L., & Liu, S. Q. (2016). Insights into protein-ligand interactions: Mechanisms, models, and methods. International Journal of Molecular Sciences, 17(2), 144. https://doi.org/10.3390/IJMS17020144

Fu, Z., Van Nostrand, W. E., & Smith, S. O. (2021). Anti-parallel β-hairpin structure in soluble Aβ oligomers of Aβ40-Dutch and Aβ40-Iowa. International Journal of Molecular Sciences, 22(3), 1225. https://doi.org/10.3390/IJMS22031225

Gohlke, H., Hendlich, M., & Klebe, G. (2000). Knowledge-based scoring function to predict protein-ligand interactions. Journal of Molecular Biology, 295(2), 337–356. https://doi.org/10.1006/JMBI.1999.3371

Kumar, J., Pandey, A., & Singh, S. P. (2020). An introduction to enzyme structure dynamics and enzyme catalysis. Biomass, Biofuels, Biochemicals: Advances in Enzyme Catalysis and Technologies, 3–10. https://doi.org/10.1016/B978-0-12-819820-9.00001-6

Leow, S. Sen, Fairus, S., & Sambanthamurthi, R. (2021). Water-soluble palm fruit extract: Composition, biological properties, and molecular mechanisms for health and non-health applications. Critical Reviews in Food Science and Nutrition, 62(32), 9076–9092. https://doi.org/10.1080/10408398.2021.1939648

Lin, Y. S., & Pande, V. S. (2012). Effects of familial mutations on the monomer structure of Aβ42. Biophysical Journal, 103(12), L47–L49. https://doi.org/10.1016/J.BPJ.2012.11.009

Mena-Ulecia, K., Tiznado, W., & Caballero, J. (2015). Study of the differential activity of thrombin inhibitors using docking, QSAR, molecular dynamics, and MM-GBSA. PLOS ONE, 10(11), e0142774. https://doi.org/10.1371/JOURNAL.PONE.0142774

Morris, G. M., Ruth, H., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/JCC.21256

Ng, W. Y., Cheung, C. Y., Milea, D., & Ting, D. S. W. (2021). Artificial intelligence and machine learning for Alzheimer’s disease: let’s not forget about the retina. British Journal of Ophthalmology, 105(5), 593–594. https://doi.org/10.1136/BJOPHTHALMOL-2020-318407

Nichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., Awasthi, A., Barker-Collo, S. L., Baune, B. T., Béjot, Y., Belachew, A. B., Bennett, D. A., Biadgo, B., Bijani, A., Bin Sayeed, M. S., … Murray, C. J. L. (2019). Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18(1), 88–106. https://doi.org/10.1016/S1474-4422(18)30403-4

Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF chimera--A visualization system for exploratory research and analysis. Journal of Comput Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084

Tagami, S., Yanagida, K., Kodama, T. S., Takami, M., Mizuta, N., Oyama, H., Nishitomi, K., Chiu, Y. Wen, Okamoto, T., Ikeuchi, T., Sakaguchi, G., Kudo, T., Matsuura, Y., Fukumori, A., Takeda, M., Ihara, Y., & Okochi, M. (2017). Semagacestat Is a pseudo-inhibitor of γ-secretase. Cell Reports, 21(1), 259–273. https://doi.org/10.1016/J.CELREP.2017.09.032

Tan, F. H. P., Ting, A. C. J., Najimudin, N., Watanabe, N., Shamsuddin, S., Zainuddin, A., Osada, H., & Azzam, G. (2023). 3-[[(3S)-1,2,3,4-Tetrahydroisoquinoline-3-carbonyl]amino] propanoic acid (THICAPA) is protective against Aβ42-induced toxicity in vitro and in an Alzheimer’s Disease Drosophila. The Journals of Gerontology: Series A, 78(11), 1944‒1952. https://doi.org/10.1093/GERONA/GLAD169

Tang, T. C., Hu, Y., Kienlen-Campard, P., El Haylani, L., Decock, M., Van Hees, J., Fu, Z., Octave, J. N., Constantinescu, S. N., & Smith, S. O. (2014). Conformational changes induced by the A21G flemish mutation in the amyloid precursor protein lead to increased Aβ production. Structure, 22(3), 387–396. https://doi.org/10.1016/J.STR.2013.12.012

Tian, G., Ghanekar, S. V., Aharony, D., Shenvi, A. B., Jacobs, R. T., Liu, X., & Greenberg, B. D. (2003). The Mechanism of γ-secretase: Multiple inhibitor binding sites for transition state analogs and small molecule inhibitors. Journal of Biological Chemistry, 278(31), 28968–28975. https://doi.org/10.1074/JBC.M300905200

Tripathi, A., & Misra, K. (2017). Molecular docking: A structure-based drug designing approach. Journal of Bioinformatics, Genomics, Proteomics, 2(1), 1015. https://www.jscimedcentral.com/public/assets/articles/bioinformatics-2-1015.pdf

VanEtten, R. L., Sebastian, J. F., Clowes, G. A., & Bender, M. L. (1967). Acceleration of phenyl ester cleavage by cycloamyloses: A model for enzymatic specificity. Journal of the American Chemical Society, 89(13), 3242–3253. https://doi.org/10.1021/JA00989A027

WHO. (2022). Supporting people living with dementia in Malaysia. https://www.who.int/westernpacific/news-room/feature-stories/item/supporting-people-living-with-dementia-in-malaysia#

Downloads

Published

17-10-2024

How to Cite

M. Suhaimi , A. M., Kamarulzaman, E. E., Wahab, H. A., & Kasihmuddin, M. S. M. (2024). In-silico approaches in designing new drug candidates (THICAPA and POET) for alzheimer’s disease. Pharmacy Education, 24(6), p. 35–42. https://doi.org/10.46542/pe.2024.246.3542